Canada hits science ties with Russia, a report finds Canada losing the chance to lead in clean competitiveness investments, MDA is awarded a lucrative Canadarm3 contract, and more.
Topic: psilocybin-assisted therapy
Canadians need safe and legal access to psychedelic drug therapy, including psilocybin
Canadians need safe and legally controlled access to psychedelic drug therapy including psilocybin-assisted therapy which, along with providing treatment for palliative patients, would provide opportunities for research and investment, says Michael Kydd, founder and principal of Kydder Group Inc., in an op-ed.